Microsaic Systems plc Result of AGM (8515Q)

TIDMMSYS

RNS Number : 8515Q

Microsaic Systems plc

30 June 2022

30 June 2022

Microsaic Systems PLC

("Microsaic" or "the Company")

Result of Annual General Meeting

The Company is pleased to announce that at its Annual General Meeting held earlier today, all five ordinary resolutions put to the meeting were duly passed. The special resolution relating to the disapplication of pre-emption rights did not achieve the required 75% of votes cast and therefore was not passed.

The voting results of the AGM were as follows:

 
 No.   Resolution                                  For*   Against 
       To approve the annual report and 
        accounts for the year ended 31 
 1      December 2021.                            65.2%    34.8 % 
       To re-appoint and authorise the 
 2      remuneration of the Company's auditor.   100.0%      0.0% 
       To re-elect Bob Moore Burton as 
 3      a director.                               99.8%      0.2% 
       To re-elect Dr Nigel Burton as 
 4      a director.                               65.2%     34.8% 
       To give the directors a general 
        authority to allot shares in the 
        Company and to grant rights to 
        subscribe for, or to convert any 
 5      security into, shares in the Company.     99.4%      0.6% 
       To empower the directors to allot 
 6      equity securities for cash.               63.4%     36.6% 
 

* Includes proxies received to be voted at the discretion of the Chairman.

 
 Enquiries: 
 Microsaic Systems plc 
  Gerry Brandon Chairman                  [phone] 
 Singer Capital Markets 
  (Nominated Adviser & Joint Broker)      [phone] 
 Aubrey Powell / Tom Salvesen / George 
  Tzimas 
 Turner Pope Investments (TPI) Limited 
  (Broker) 
  Andy Thacker / James Pope               [phone] 
 
 

About Microsaic

Microsaic develops and commercialises micro-engineering chip-based mass spectrometry equipment. Microsaic has a robust patent portfolio in cutting-edge technology purpose built for "Industry 4.0" which enables analytical detection and characterisation at the point-of-need, whether within a human health environment, conventional laboratory setting, or within a bioprocessing facility for continuous mass spectrometer detection and monitoring of data at any step in the process workflow , or in frontline environmental monitoring

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RAGFMMBTMTMJBLT

(END) Dow Jones Newswires

June 30, 2022 07:12 ET (11:12 GMT)